Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.21 USD | -0.90% | -12.65% | -26.58% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 337.6 | 219.5 | 209.1 | 155.6 | - | - |
Enterprise Value (EV) 1 | 337.6 | 219.5 | 209.1 | 155.6 | 155.6 | 155.6 |
P/E ratio | - | - | - | - | - | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | 151 x | 22 x |
EV / Revenue | - | - | - | - | 151 x | 22 x |
EV / EBITDA | - | -7.04 x | -6.04 x | -4.24 x | -3.42 x | -10.4 x |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 34,375 | 69,012 | 69,474 | 69,797 | - | - |
Reference price 2 | 9.820 | 3.180 | 3.010 | 2.230 | 2.230 | 2.230 |
Announcement Date | 3/28/22 | 3/9/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | 1.03 | 7.081 |
EBITDA 1 | - | -31.16 | -34.61 | -36.71 | -45.45 | -14.91 |
EBIT 1 | -13.79 | -32.14 | -35.68 | -36.89 | -45.23 | -42.47 |
Operating Margin | - | - | - | - | -4,391.71% | -599.81% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - |
EPS | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/28/22 | 3/9/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | 0.025 | 0.05 | 0.15 |
EBITDA 1 | - | - | - | - | - | - | - | - | -10.14 | -8.634 | -9.086 | -9.604 | -10.43 |
EBIT 1 | -8.781 | -8.012 | -7.358 | -7.985 | -8.644 | -8.168 | -7.339 | -9.943 | -8.424 | -8.917 | -9.476 | -10.08 | -11.06 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | -37,903.08% | -20,152.24% | -7,372.46% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 5/26/22 | 8/25/22 | 11/22/22 | 3/9/23 | 5/23/23 | 8/28/23 | 11/16/23 | 3/7/24 | 5/20/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | -95.3% | -30.7% | -40.4% | -41.5% | -7.57% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | 2.93 | 0.9 | 6.4 | 4 | 6 | - |
Capex / Sales | - | - | - | - | 582.52% | - |
Announcement Date | 3/28/22 | 3/9/23 | 3/7/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.91% | 156M | |
+94.72% | 1.23B | |
+2.57% | 986M | |
+29.03% | 843M | |
+2.30% | 668M | |
-0.36% | 604M | |
-.--% | 600M | |
+10.28% | 536M | |
-.--% | 500M | |
-7.43% | 470M |
- Stock Market
- Equities
- DRTS Stock
- Financials Alpha Tau Medical Ltd.